Yu Xia

机构：China Meteorological Administration, Hangzhou Normal University, The University of Texas at San Antonio Health Science Center, Washington University in St. Louis, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Mianyang Normal University, National Clinical Research Center for Digestive Diseases, Guangzhou Blood Center, Zhongshan People's Hospital, Shanghai Blood Center, Tongji Hospital, First Affiliated Hospital Zhejiang University, State Key Laboratory of Diagnosis and Treatment of Infectious Diseases, Huazhong University of Science and Technology, Ocean University of China · ORCID：0000-0002-6397-1205

发表论文 148 篇 · 总被引 3377 次 · h-index 31

代表论文

• Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors (2024 · Cell · 被引 108)
• CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells (2025 · Trends in Immunology · 被引 40)
• Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China (2025 · Nature Communications · 被引 12)
• Single-cell analysis identifies RETN + monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure (2025 · Gut · 被引 11)
• Design and tribological performance of graphene nanofluids dispersed by dragging effect of bicomponent gelator (2024 · Nanotechnology · 被引 11)
• Real-Time Cucumber Target Recognition in Greenhouse Environments Using Color Segmentation and Shape Matching (2024 · Applied Sciences · 被引 9)